Brean Murray assumes coverage on China Medical Technologies (Nasdaq: CMED) with a Buy.

Brean analyst says, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE